EVOGENE LTD (EVGN)
IL0011050551 - Common Stock
EVOGENE LTD
NASDAQ:EVGN (5/3/2024, 7:00:01 PM)
After market: 0.6951 -0.01 (-2.1%)0.71
+0 (+0.64%)
Company Profile
Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Company Info
EVOGENE LTD
Park Rehovot P.O.B 2100, 13 Gad Feinstein Street
Rehovot 7414002
P: 97289311900
CEO: Ofer Haviv
Employees: 137
Website: https://evogene.com/
EVGN News
18 days ago - Biomica Ltd.Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting/PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....
23 days ago - Biomica Ltd.Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting/PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....
a month ago - EvogeneEvogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science-based product...
a month ago - EvogeneEvogene Announces Filing of Annual Report on Form 20-F/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science-based product...
2 months ago - Lavie BioBayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing/PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company that develops microbiome-based, computational-driven bio-stimulant and bio-pesticide novel...
2 months ago - InvestorPlaceEVGN Stock Earnings: Evogene Beats EPS, Misses Revenue for Q4 2023EVGN stock results show that Evogene beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
EVGN Twits
Here you can normally see the latest stock twits on EVGN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
